Amplia Therapeutics Limited (ASX:ATX)

Revenue by Product

Fiscal year is April - March.

Year Ending	Mar 31, 2023	Mar 31, 2022
Focal Adhesion Kinase	15.00K	Log In
Focal Adhesion Kinase Growth	-63.46%	Log In

Revenue by Geography

Fiscal year is April - March.

Year Ending	Mar 31, 2023	Mar 31, 2022
Australia	15.00K	Log In
Australia Growth	-63.46%	Log In